Lin-Zi Li

600 total citations
22 papers, 443 citations indexed

About

Lin-Zi Li is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, Lin-Zi Li has authored 22 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Pharmacology and 4 papers in Epidemiology. Recurrent topics in Lin-Zi Li's work include Biological and pharmacological studies of plants (6 papers), Ginseng Biological Effects and Applications (5 papers) and Gut microbiota and health (5 papers). Lin-Zi Li is often cited by papers focused on Biological and pharmacological studies of plants (6 papers), Ginseng Biological Effects and Applications (5 papers) and Gut microbiota and health (5 papers). Lin-Zi Li collaborates with scholars based in China, Poland and Australia. Lin-Zi Li's co-authors include Guiyuan Lv, Suhong Chen, Yingjie Dong, Xiang Zheng, Jie Su, Xinglishang He, Bo Li, Qiao-Xian Yu, Xi Fang and Rong Luo and has published in prestigious journals such as Frontiers in Microbiology, Journal of Ethnopharmacology and European Journal of Pharmacology.

In The Last Decade

Lin-Zi Li

21 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lin-Zi Li China	11	169	104	68	55	45	22	443
Saptadip Samanta India	15	212 1.3×	51 0.5×	118 1.7×	77 1.4×	30 0.7×	37	652
Mehran Hosseini Iran	15	91 0.5×	101 1.0×	52 0.8×	71 1.3×	70 1.6×	64	643
Won‐Hee Choi South Korea	10	146 0.9×	52 0.5×	74 1.1×	50 0.9×	71 1.6×	40	503
Stephanie Maxine Ross United States	11	101 0.6×	60 0.6×	66 1.0×	68 1.2×	74 1.6×	98	500
Xiaocao Liu China	11	165 1.0×	39 0.4×	61 0.9×	80 1.5×	54 1.2×	52	818
Soo Liang Ooi Australia	12	85 0.5×	43 0.4×	52 0.8×	54 1.0×	38 0.8×	32	439
Emiliano Ricardo Vasconcelos Rios Brazil	14	152 0.9×	73 0.7×	110 1.6×	114 2.1×	98 2.2×	19	621
Alpana Ram India	15	177 1.0×	50 0.5×	90 1.3×	25 0.5×	75 1.7×	41	753
Juliana Cavalli Brazil	11	97 0.6×	66 0.6×	35 0.5×	41 0.7×	33 0.7×	15	368
Majid Emtiazy Iran	14	97 0.6×	61 0.6×	91 1.3×	49 0.9×	80 1.8×	39	626

Countries citing papers authored by Lin-Zi Li

Since Specialization

Citations

This map shows the geographic impact of Lin-Zi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin-Zi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin-Zi Li more than expected).

Fields of papers citing papers by Lin-Zi Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin-Zi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin-Zi Li. The network helps show where Lin-Zi Li may publish in the future.

Co-authorship network of co-authors of Lin-Zi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lin-Zi Li. A scholar is included among the top collaborators of Lin-Zi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin-Zi Li. Lin-Zi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Xinglishang, Wanfeng Xu, Lin-Zi Li, et al.. (2025). Network-based pharmacological and experimentally validated study on the therapeutic effects and mechanisms of Polygonatum Rhizoma Ginseng Formula in immunocompromised mice. Journal of Ethnopharmacology. 348. 119821–119821. 1 indexed citations

Huang, Chenchen, Rui Duan, Lin-Zi Li, et al.. (2025). Gut microbiome dynamics and functional shifts in healthy aging: insights from a metagenomic study. Frontiers in Microbiology. 16. 1629811–1629811.

Li, Bo, Jie Su, Zehua Zhang, et al.. (2024). The anti-hyperlipidemia effect of Atractylodes macrocephala Rhizome increased HDL via reverse cholesterol transfer. Heliyon. 10(7). e28019–e28019. 2 indexed citations

Li, Lin-Zi, Bo Li, Xiang Zheng, et al.. (2023). Effects of a Macroporous Resin Extract of Dendrobium officinale Leaves in Rats with Hyperuricemia Induced by Anthropomorphic Unhealthy Lifestyle. Evidence-based Complementary and Alternative Medicine. 2023(1). 9990843–9990843. 9 indexed citations

Li, Lin-Zi, Lin Chen, MA Ya, et al.. (2023). Protective mechanism of quercetin compounds against acrylamide-induced hepatotoxicity. Food Science and Human Wellness. 13(1). 225–240. 10 indexed citations

Li, Lin-Zi, et al.. (2023). Physician Empathy in Doctor-Patient Communication: A Systematic Review. Health Communication. 39(5). 1027–1037. 35 indexed citations

Li, Lin-Zi, et al.. (2023). Alisol B blocks the development of HFD-induced obesity by triggering the LKB1-AMPK signaling in subcutaneous adipose tissue. European Journal of Pharmacology. 956. 175942–175942. 8 indexed citations

Cheng, Bingbing, Bo Li, Xiang Zheng, et al.. (2023). Beneficial effects of Hawthorn extract on metabolic hypertensive rats by regulating Treg/Th17 immune balance. Journal of Functional Foods. 108. 105750–105750. 4 indexed citations

Li, Lin-Zi, Huiying Wang, Jia-Hui Huang, et al.. (2022). The Mechanism of Dendrobium officinale as a Treatment for Hyperlipidemia Based on Network Pharmacology and Experimental Validation. Evidence-based Complementary and Alternative Medicine. 2022. 1–23. 7 indexed citations

10.

Li, Bo, Huiying Wang, Jia-Hui Huang, et al.. (2022). Polysaccharide, the Active Component of Dendrobium officinale, Ameliorates Metabolic Hypertension in Rats via Regulating Intestinal Flora-SCFAs-Vascular Axis. Frontiers in Pharmacology. 13. 935714–935714. 27 indexed citations

11.

Zheng, Xiang, Yingjie Dong, Bingbing Cheng, et al.. (2022). Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-κB pathway. Journal of Ethnopharmacology. 289. 115001–115001. 94 indexed citations

12.

Chen, Suhong, et al.. (2022). Pitongshu Alleviates the Adverse Symptoms in Rats with Functional DyspepsiaThrough Regulating Visceral Hypersensitivity Caused by 5-HTOverexpression. Combinatorial Chemistry & High Throughput Screening. 26(7). 1424–1436. 5 indexed citations

13.

Zheng, Xiang, Huiying Wang, Bo Li, et al.. (2021). Benefit Effect of Dendrobium officinale Ultrafine Powder on DSS-Induced Ulcerative Colitis Rats by Improving Colon Mucosal Barrier. Evidence-based Complementary and Alternative Medicine. 2021. 1–10. 15 indexed citations

14.

Lei, Shanshan, Xinglishang He, Huiying Wang, et al.. (2021). Dendrobium officinale Regulates Fatty Acid Metabolism to Ameliorate Liver Lipid Accumulation in NAFLD Mice. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 17 indexed citations

15.

Dong, Yingjie, Lianghui Zhan, Xi Fang, et al.. (2021). Soporific effect of modified Suanzaoren Decoction on mice models of insomnia by regulating Orexin-A and HPA axis homeostasis. Biomedicine & Pharmacotherapy. 143. 112141–112141. 68 indexed citations

16.

Lv, Guiyuan, Suhong Chen, Yuzhi Wang, et al.. (2021). Effects of Macroporous Resin Extract of Dendrobium officinale Leaves inRats with Hyperuricemia Induced by Fructose and Potassium Oxonate. Combinatorial Chemistry & High Throughput Screening. 25(8). 1294–1303. 7 indexed citations

17.

Li, Bo, Xinglishang He, Huiying Wang, et al.. (2021). Beneficial effects ofDendrobium officinaleon metabolic hypertensive rats by triggering the enteric-origin SCFA-GPCR43/41 pathway. Food & Function. 12(12). 5524–5538. 35 indexed citations

18.

Zhang, Dewu, Yujia Wang, Xinxin Hu, et al.. (2021). Cyclic and Linear Thiopeptides from Soil‐DerivedStreptomyces sp. CPCC 203702 with Antiviral and Antibacterial Activities. Chinese Journal of Chemistry. 39(12). 3277–3284. 10 indexed citations

19.

Li, Bo, Xinglishang He, Shanshan Lei, et al.. (2020). Hypertensive Rats Treated Chronically With Nω-Nitro-L-Arginine Methyl Ester (L-NAME) Induced Disorder of Hepatic Fatty Acid Metabolism and Intestinal Pathophysiology. Frontiers in Pharmacology. 10. 1677–1677. 32 indexed citations

20.

Guo, Jianan, Xiaoying Jiang, Changjun Zhang, et al.. (2020). Design, synthesis and biological evaluation of potential anti-AD hybrids with monoamine oxidase B inhibitory and iron-chelating effects. Bioorganic Chemistry. 108. 104564–104564. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact